Cannabinoid signalling
- PMID: 16109430
- DOI: 10.1016/j.lfs.2005.05.055
Cannabinoid signalling
Abstract
After their discovery, the two known cannabinoid receptors, CB(1) and CB(2), have been the focus of research into the cellular signalling mechanisms of cannabinoids. The initial assessment, mainly derived from expression studies, was that cannabinoids, via G(i/o) proteins, negatively modulate cyclic AMP levels, and activate inward rectifying K(+) channels. Recent findings have complicated this assessment on different levels: (1) cannabinoids include a wide range of compounds with varying profiles of affinity and efficacy at the known CB receptors, and these profiles do not necessarily match their biological activity; (2) CB receptors appear to be intrinsically active and possibly coupled to more than one type of G protein; (3) CB receptor signalling mechanisms are diverse and dependent on the system studied; (4) cannabinoids have other targets than CB receptors. The aim of this mini review is to discuss the current literature regarding CB receptor signalling pathways. These include regulation of adenylyl cyclase, MAP kinase, intracellular Ca(2+), and ion channels. In addition, actions of cannabinoids that are not mediated by CB(1) or CB(2) receptors are discussed.
Similar articles
-
CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids.Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):161-71. doi: 10.1054/plef.2001.0344. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052033 Review.
-
The neurobiology and evolution of cannabinoid signalling.Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408. doi: 10.1098/rstb.2000.0787. Philos Trans R Soc Lond B Biol Sci. 2001. PMID: 11316486 Free PMC article. Review.
-
Cannabinoid signalling in the enteric nervous system.Neurogastroenterol Motil. 2009 Sep;21(9):899-902. doi: 10.1111/j.1365-2982.2009.01372.x. Neurogastroenterol Motil. 2009. PMID: 19689654
-
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.J Natl Cancer Inst. 2008 Jan 2;100(1):59-69. doi: 10.1093/jnci/djm268. Epub 2007 Dec 25. J Natl Cancer Inst. 2008. PMID: 18159069
-
Signal transduction of the CB1 cannabinoid receptor.J Mol Endocrinol. 2010 Feb;44(2):75-85. doi: 10.1677/JME-08-0190. Epub 2009 Jul 20. J Mol Endocrinol. 2010. PMID: 19620237 Review.
Cited by
-
Activation of cannabinoid receptor 2 inhibits experimental cystitis.Am J Physiol Regul Integr Comp Physiol. 2013 May 15;304(10):R846-53. doi: 10.1152/ajpregu.00585.2012. Epub 2013 Mar 20. Am J Physiol Regul Integr Comp Physiol. 2013. PMID: 23515618 Free PMC article.
-
A review of the direct targets of the cannabinoids cannabidiol, Δ9-tetrahydrocannabinol, N-arachidonoylethanolamine and 2-arachidonoylglycerol.AIMS Neurosci. 2024 Apr 30;11(2):144-165. doi: 10.3934/Neuroscience.2024009. eCollection 2024. AIMS Neurosci. 2024. PMID: 38988890 Free PMC article. Review.
-
Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.Recent Pat CNS Drug Discov. 2012 Apr 1;7(1):25-40. doi: 10.2174/157488912798842269. Recent Pat CNS Drug Discov. 2012. PMID: 22280339 Free PMC article. Review.
-
Local activation of CB1 receptors by synthetic and endogenous cannabinoids dampens burst firing mode of reticular thalamic nucleus neurons in rats under ketamine anesthesia.Exp Brain Res. 2024 Sep;242(9):2137-2157. doi: 10.1007/s00221-024-06889-6. Epub 2024 Jul 9. Exp Brain Res. 2024. PMID: 38980339
-
Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.Br J Pharmacol. 2007 Nov;152(5):583-93. doi: 10.1038/sj.bjp.0707399. Epub 2007 Jul 16. Br J Pharmacol. 2007. PMID: 17641667 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous